It is our great pleasure to invite you for the 20th European AIDS Conference in Paris from 15-18 October 2025.
Despite significant progress towards ending HIV epidemics notable challenges remain both from prevention and clinical perspective. In many countries and regions combination prevention including HIV pre-exposure prophylaxis is still suboptimal and of limited availability due to an array of barriers including financial, system capacity and stigma which call for urgent action. Sadly, despite years of efforts late HIV diagnoses remain common affecting all genders and ages therefore expanding access to testing with implementation of novel testing modalities is also key. HIV epidemics is also often silently affecting vulnerable populations including women, migrants and transgender people calling for focused prevention and treatment action. Furthermore, Eastern European regions remain to be disproportionately affected by the growing epidemics which challenges the progress towards meeting the incidence reduction target. Continuous disastrous war in Ukraine further exacerbates the issue not only with massive casualties and limiting access to care but forcing displacement and migration of notable proportion of people living with HIV.
With this biennial conference we invite healthcare professionals, scientist and community to exchange knowledge but mostly inspire and forge collaborations linking people from different backgrounds and regions, allowing to bridge the transfer of knowledge and expertise. Tradition of EACS conferences as an open floor for high quality science is long standing and we invite all participants to act on this opportunity. This marks the second time the Conference has been held in the city of Paris in a span of 33 years.
The city of Paris played a significant role in the fight against HIV as the location where the first Declaration on Fast-Track Cities to end the HIV epidemic was signed on World AIDS Day in 2014.
With the theme “From Science to Implementation”, the 20th European AIDS Conference aims to not only revisit the vibrant city of Paris but also emphasize our commitment to translating scientific and clinical advancements in the field into effective policies for ending the HIV epidemic. Central to our discussions will be:
The pursuit of access equality in prevention and treatment
The advances in vaccine and cure research
Scientific and clinical progress in antiretroviral therapy, coinfections and comorbidities
Reinforcing the clinical science in women including pregnancy, children and adolescents
Focus on vulnerable and marginalized populations
Increasing public awareness and focus on policy of public health
The collaboration with communities and patient organisations
Hosting the Conference in Paris highlights the city’s significant role in global health, showcasing its cultural depth and history of innovation, making it an ideal setting for important discussions on HIV/AIDS prevention and care.
